Drug utilization in Canadian patients with major chronic diseases

American Journal of Pharmacy Benefits

Volumn 3, Issue 2, 2011, Pages

  Mo, Frank ^a,b   Morrison, Howard ^a   Liepold, Heidi ^a   Underhill, Lisa ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; ASTHMA; CANADA; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSULTATION; DIABETES MELLITUS; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH INSURANCE; HEALTH STATUS; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBESITY; SEDENTARY LIFESTYLE;

EID: 84859741254     PISSN: 19454481     EISSN: 21642494     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Patra J, Popova S, Rhm J, Bondy S, Flint R, Giesbrecht N. Economic cost of chronic disease in Canada 1995-2003. http://www.ocdpa.on.ca/docs/OCDPA_EconomicCosts.pdf. Accessed November 20, 2009.
2. Gadalla T. Association of comorbid mood disorders and chronic illness with disability and quality of life in Ontario, Canada. Chronic Dis Can. 2008;28(4): 148-154.
3. Schultz SE, Kopec JA. Impact of chronic conditions. Health Rep. 2003;14(4):41-53.
4. Campbell NR, McAlister FA, Brant R, et al; Canadian Hypertension Education Process and Evaluation Committee. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens. 2003;21(8):1591-1597.
5. Campbell NR, Brant R, Johansen H, et al; Canadian Hypertension Education Program Outcomes Research Task Force. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension. 2009;53 (2):128-134.
6. Onysko J, Maxwell C, Eliasziw M, Zhang J, Johansen H, Campbell N; Canadian Hypertension Education Program. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension. 2006;48(5):853-860.
7. Mueller C, Schur C, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health. 1997;87(10):1626-1629.
8. Cross LB, Franks AS. Clinical outcomes associated with pharmacist involvement in patients with dyslipidemia. Dis Manage Health Outcomes. 2005;13(1):31-42.
9. Nicholas A, Divine H, Nowak-Rapp M, Roberts KB. University and college of pharmacy collaboration to control health plan prescription drug costs. J Am Pharm Assoc. 2007;47(1):86-92.
10. Strand LM, Cipolle RJ, Morley PC, Frakes MJ. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des. 2004;10(31):3987-4001.
11. Petrilla AA, Benner JS, Battleman DS, Tierce JC, Hazard EH. Evidence-based interventions to improve patient compliance with antihypertensive and lipidlowering medications. Int J Clin Pract. 2005;59(12):1441-1451.
12. Spiers MV, Kutzik DM, Lamar M. Variation in medication understanding among the elderly. Am J Health Syst Pharm. 2004;61(4):273-280.
13. Aspden P, Wolcott JA, Bootman JL, Cronenwett LR, eds; Committee on Identifying and Preventing Medication Errors. Preventing Medication Errors. Washington, DC: The National Academies Press; 2007.
14. Coffey E, Moscovice I, Finch M, Christianson JB, Lurie N. Capitated Medicaid and the process of care of elderly hypertensives and diabetics: results from a randomized trial. Am J Med. 1995;98(6):531-536.
15. Mehuys E, De Bolle L, Van Bortel L, et al. Medication use and disease management of type 2 diabetes in Belgium. Pharm World Sci. 2008;30(1):51-56.
16. Organisation for Economic Co-operation and Development. OECD health data 2010-selected data. http://stats.oecd.org/Index.aspx. Accessed October 15, 2010.
17. Phatak HM, Thomas J 3rd. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 2006; 40(10):1737-1742.
18. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27(7):1104-1111.
19. Lewis NJ, Bugdalski-Stutrud C, Abate MA, Blommel M, Wu CH, Gaither CA. The Medication Assessment Program: comprehensive medication assessments for persons taking multiple medications for chronic diseases. J Am Pharm Assoc. 2008;48(2):171-180.
20. World Health Organization. Obesity and overweight. What are overweight and obesity? Factsheet No. 311. http://www.who.int/mediacentre/factsheets/fs311/en/. Published March 25, 2011. Accessed April 18, 2011.
21. Statistics Canada. Documentation for CCHS 2.1. http://www.statcan.gc.ca/daily-quotidien/.../dq040615b-eng.htm. Published June 15, 2004. Accessed October 15, 2010.
22. Taylor BC, Noorbaloochi S, McNaughton-Collins M, et al; Urologic Diseases in America Project. Excessive antibiotic utilization in men with prostatitis. Am J Med. 2008;121(5):444-449.
23. Kozyrskyj AL, Ernst P, Becker AB. Increased risk of childhood asthma from antibiotic use in early life. Chest. 2007;131(6):1753-1759.
24. Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes NC. Antibiotics for exacerbations of chronic obstructive pulmonary disease [update in: Cochrane Database Syst Rev. 2011;1:CD004403]. Cochrane Database Syst Rev. 2006;(2):CD004403.
25. Kilkkinen A, Rissanen H, Klaukka T, et al. Antibiotic use predicts an increased risk of cancer. Int J Cancer. 2008;123(9):2152-2155.
26. Silverstein LJ, Bailey RM, St Jeor ST. The role of weight loss drugs in the treatment of obesity in women. J Womens Health. 1998;7(2):187-188.
27. Clark JM, Brancati FL. The challenge of obesity-related chronic diseases. J Gen Intern Med. 2000;15(11):828-829.
28. Tsai LW. Pharmacological management of obesity. Prim Care Update Ob/Gyns. 1998;5(2):101-107.
29. Renzaho AM, Mellor D, Boulton K, Swinburn B. Effectiveness of prevention programmes for obesity and chronic diseases among immigrants to developed countries - a systematic review. [published online ahead of print September 2, 2009] Public Health Nutr. 2010; 13(3):438-450. http://www.ncbi.nlm.nih.gov/pubmed/19723366. Accessed April 18, 2011.
30. Health Canada. Extended Health, Dental, and Accident Insurance Care Plan. December 31, 2008. http://cupwwpg.ca/wp-content/uploads/2010/10/ben_ehcp_eng.pdf. Accessed April 18, 2011.
31. DesMeules M, Stewart D, eds. Women's Health Surveillance Report. A Multidimensional Look at the Health of Canadian Women. Ottawa, Canada: Health Canada; 2003.